OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $609,995 | -39.1% | 194,266 | 0.0% | 0.09% | -28.8% |
| Q2 2023 | $1,002,413 | -2.1% | 194,266 | 0.0% | 0.13% | -2.9% |
| Q1 2023 | $1,023,782 | +87.5% | 194,266 | 0.0% | 0.14% | +83.8% |
| Q4 2022 | $545,887 | -32.3% | 194,266 | 0.0% | 0.07% | -36.2% |
| Q3 2022 | $806,000 | +3.2% | 194,266 | 0.0% | 0.12% | +9.4% |
| Q2 2022 | $781,000 | -18.8% | 194,266 | 0.0% | 0.11% | -7.0% |
| Q1 2022 | $962,000 | -29.0% | 194,266 | 0.0% | 0.11% | -23.0% |
| Q4 2021 | $1,354,000 | -30.3% | 194,266 | 0.0% | 0.15% | -23.3% |
| Q3 2021 | $1,943,000 | -29.5% | 194,266 | 0.0% | 0.19% | -37.1% |
| Q2 2021 | $2,755,000 | -13.6% | 194,266 | 0.0% | 0.31% | -14.2% |
| Q1 2021 | $3,188,000 | -21.3% | 194,266 | -0.8% | 0.36% | -39.2% |
| Q4 2020 | $4,052,000 | +171.9% | 195,766 | 0.0% | 0.59% | +205.2% |
| Q3 2020 | $1,490,000 | +0.8% | 195,766 | 0.0% | 0.19% | +114.4% |
| Q2 2020 | $1,478,000 | +97.9% | 195,766 | +29.7% | 0.09% | -20.4% |
| Q1 2020 | $747,000 | +25.3% | 150,946 | 0.0% | 0.11% | +41.2% |
| Q4 2019 | $596,000 | +0.2% | 150,946 | -22.9% | 0.08% | +2.6% |
| Q3 2019 | $595,000 | -8.0% | 195,766 | +33.2% | 0.08% | -15.2% |
| Q2 2019 | $647,000 | +11.0% | 146,946 | 0.0% | 0.09% | +8.2% |
| Q1 2019 | $583,000 | -42.3% | 146,946 | 0.0% | 0.08% | -44.4% |
| Q4 2018 | $1,011,000 | 0.0% | 146,946 | 0.0% | 0.15% | -0.6% |
| Q3 2018 | $1,011,000 | +5.6% | 146,946 | 0.0% | 0.15% | +2.0% |
| Q2 2018 | $957,000 | 0.0% | 146,946 | 0.0% | 0.15% | -7.9% |
| Q1 2018 | $957,000 | +46.3% | 146,946 | 0.0% | 0.16% | +84.3% |
| Q4 2017 | $654,000 | -26.8% | 146,946 | +1.7% | 0.09% | -29.4% |
| Q3 2017 | $893,000 | -33.3% | 144,446 | 0.0% | 0.13% | -36.0% |
| Q2 2017 | $1,339,000 | -0.1% | 144,446 | 0.0% | 0.20% | -6.2% |
| Q1 2017 | $1,340,000 | +10.8% | 144,446 | 0.0% | 0.21% | +1.4% |
| Q4 2016 | $1,209,000 | -7.0% | 144,446 | -23.7% | 0.21% | -10.0% |
| Q3 2016 | $1,300,000 | +38.7% | 189,266 | 0.0% | 0.23% | +32.9% |
| Q2 2016 | $937,000 | -45.1% | 189,266 | +3.8% | 0.17% | -45.6% |
| Q1 2016 | $1,708,000 | 0.0% | 182,266 | 0.0% | 0.32% | 0.0% |
| Q4 2015 | $1,708,000 | -34.4% | 182,266 | -1.6% | 0.32% | -32.6% |
| Q3 2015 | $2,604,000 | -28.0% | 185,235 | +7.7% | 0.47% | -20.7% |
| Q2 2015 | $3,617,000 | -47.3% | 171,985 | +5.2% | 0.60% | -47.5% |
| Q1 2015 | $6,865,000 | – | 163,516 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |